NIMH Collaborative HIV/STD Prevention Trial Group. Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS 2007 Apr;21 Suppl 2:S91-8.
The NIMH Collaborative HIV/STD Prevention trial group sought to obtain information about the social and cultural factors related to health behaviours influencing HIV/sexually transmitted disease (STD) transmission in study communities [...]
Welcome to the thirty-third issue HIV This Week! In this issue, we cover HIV prevention (sexual power dynamics and what makes a popular opinion leader on four continents; impact of “Staying Alive” in Nepal, Brazil and Senegal), gender (do women have clinical and viro-immunological advantages over men?), epidemiology (per-partnership transmission probabilities for young South African women; [...]
NIMH Collaborative HIV/STD Prevention Trial Group. Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS 2007 Apr;21 Suppl 2:S91-8.
The NIMH Collaborative HIV/STD Prevention trial group sought to obtain information about the social and cultural factors related to health behaviours influencing HIV/sexually transmitted disease (STD) transmission in study communities [...]
Collazos J, Asensi V, Carton JA; for the Grupo Espanol para el Estudio Multifactorial de la Adherencia (GEEMA). Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS 2007;21(7):835-43.
Callazos and colleagues’ objectives were to compare the clinical, virological and immunological parameters of men and women at baseline and during [...]
Pettifor AE, Hudgens MG, Levandowski BA, Rees HV, Cohen MS. Highly efficient HIV transmission to young women in South Africa. AIDS 2007;21:861-865.
Young women in sub-Saharan Africa are at very high risk of HIV acquisition, and high prevalence levels have been observed among women reporting one lifetime partner and few sexual contacts. Such findings have [...]
Herbst JH, Beeker C, Mathew A, McNally T, Passin WF, Kay LS, Crepaz N, Lyles CM, Briss P, Chattopadhyay S, Johnson RL; Task Force on Community Preventive Services. The Effectiveness of Individual-, Group-, and Community-Level HIV Behavioral Risk-Reduction Interventions for Adult Men Who Have Sex with Men A Systematic Review. Am J Prev Med 2007;32(4 [...]
Krieger JN, Bailey RC, Opeya JC, Ayieko BO, Opiyo FA, Omondi D, Agot K, Parker C, Ndinya-Achola JO, Moses S. Adult male circumcision outcomes: experience in a developing country setting. Urol Int 2007;78:235-40.
Krieger and colleagues examined male circumcision outcomes among young adults in an African setting. Participants were healthy, sexually active, uncircumcised, HIV-seronegative males [...]
Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, Harries AD. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006 Nov 28;20(18):2355-60.
Zachariah and colleagues’ objectives were, among adults started on antiretroviral treatment (ART) in a rural district hospital, (a) to determine [...]
Campos-Outcalt D. Time to revise your HIV testing routine. J Fam Pract 2007;56:283-4.
Should all adults and adolescents be screened for HIV? Do all persons at high risk deserve annual screening? The Centers for Disease Control and Prevention (CDC) thinks so, but the US Preventive Services Task Force takes a less aggressive stance. The two [...]
Diaz Munoz L, Serramia MJ, Fresno M, Munoz-Fernandez MA. Progesterone inhibits HIV-1 replication in human trophoblast cells through inhibition of autocrine tumor necrosis factor secretion. J Infect Dis 2007;195:1294-302.
Progesterone levels are higher in placental barriers during pregnancy, but the effect of progesterone on human immunodeficiency virus type 1 (HIV-1) infection in placental cells has [...]
Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Educ Prev 2007;19:124-136.
This study assessed injection-related HIV risk behavioural changes among opioid users 6 months after enrollment in low-threshold (harm reduction based) methadone [...]
Guillen S, Ramos JT, Resino R, Bellon JM, Munoz MA. Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J 2007;26:334-8.
There are few data on long-term effects of highly active antiretroviral therapy (HAART) on weight and height in HIV-infected children. Guillen and colleagues’ assess the effect of HAART [...]
Welcome to the thirty-second issue of HIV This Week! In this issue, we learn why understanding resilience is as important as understanding vulnerability (the role of community safety nets; equity, social cohesion, solidarity and inclusion; and the social dynamics of orphan care), basic science (promising first steps in gene therapy for advanced immunodeficiency; Vitamin A [...]
Foster G. Under the radar: community safety nets for AIDS-affected households in sub-Saharan Africa. AIDS Care 2007;19 Suppl 1:S54-63.
Safety nets are mechanisms to mitigate the effects of poverty on vulnerable households during times of stress. In sub-Saharan Africa, extended families, together with communities, are the most effective responses enabling access to support for households [...]
Lunzen J, Glaunsinger T, Stahmer I, Baehr V, Baum C, Schilz A, Kuehlcke K, Naundorf S, Martinius H, Hermann F, Giroglou T, Newrzela S, Muller I, Brauer F, Brandenburg G, Alexandrov A, von Laer D. Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. Mol Ther 2007;15:1024-33.
Drug toxicity [...]
